Form 4: Aline Sherwood, Director at Bio-Path Holdings, Acquires Options
SEC Form 4
Director Aline Sherwood acquired options to purchase 2,000 shares of Bio-Path Holdings stock at $1.55 per share.
Summary
- On July 30, 2024, Aline Sherwood, a director at Bio-Path Holdings, Inc., acquired options to purchase 2,000 shares of common stock.
- The exercise price of the options is $1.55 per share.
- The options vest over a one-year period, with shares vesting in equal monthly increments.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option acquisition by a director.
Positives
- The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock.
Stakeholder Impact
- The acquisition of options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/30/2024 | Date of transaction: Aline Sherwood acquired options to purchase 2,000 shares of Bio-Path Holdings stock. |
| 07/30/2024 | Options vest over a one-year period, with the shares vesting in equal monthly increments. |
| 07/31/2024 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Options, Director, BIO-PATH HOLDINGS, BPTH, Aline Sherwood
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.